MedTrace Logo

Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery

NCT00257868 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2007-07-31

No results posted yet for this study

Summary

The purpose of this study is to determine whether Rivastigmine is effective for the prevention of postoperative delirium in patients undergoing cardiac surgery.

Conditions

  • Delirium

Interventions

DRUG

Rivastigmine prevention of delirium

Sponsors & Collaborators

  • Novartis

    collaborator INDUSTRY

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Luzius A Steiner, MD PhD · Department of Anaesthesia, University Hospital Basel, Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Completion
2007-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00257868 on ClinicalTrials.gov